| Q37268111 | A cerebrovascular perspective of atherosclerosis |
| Q51655908 | A finite element model for performing intravascular ultrasound elastography of human atherosclerotic coronary arteries. |
| Q35075416 | A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifications in thin fibrous caps |
| Q36306954 | A uni-extension study on the ultimate material strength and extreme extensibility of atherosclerotic tissue in human carotid plaques |
| Q30444793 | Acoustic radiation force impulse imaging of vulnerable plaques: a finite element method parametric analysis |
| Q30490718 | Acute coronary syndromes: diagnosis and management, part I |
| Q71820204 | Acute myocardial infarction - the angiographic picture: new insights into the pathogenesis of myocardial infarction |
| Q43429541 | Alternative hypothesis for efficacy of macrolides in acute coronary syndromes |
| Q37438768 | An experimental study on the ultimate strength of the adventitia and media of human atherosclerotic carotid arteries in circumferential and axial directions |
| Q34490930 | Apoptosis in atherosclerosis. Does it contribute to plaque instability? |
| Q35782561 | Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. |
| Q79756351 | Arterial wall cholesterol content is a predictor of development and severity of arterial thrombosis |
| Q33613217 | Arteriographic view of treatment to achieve regression of coronary atherosclerosis and to prevent plaque disruption and clinical cardiovascular events |
| Q39794511 | Astaxanthin suppresses scavenger receptor expression and matrix metalloproteinase activity in macrophages |
| Q48579592 | Atheromatous plaque cap thickness can be determined by quantitative color analysis during angioscopy: implications for identifying the vulnerable plaque. |
| Q40872795 | Atherosclerosis: what is it and why does it occur? |
| Q30673065 | Axial strain imaging of intravascular data: results on polyvinyl alcohol cryogel phantoms and carotid artery |
| Q39127509 | Biomechanical factors in atherosclerosis: mechanisms and clinical implications |
| Q37799366 | Biomechanical structural stresses of atherosclerotic plaques |
| Q39297021 | Broad regulation of matrix and adhesion molecules in THP-1 human macrophages by nitroglycerin |
| Q34186648 | Broad-spectrum chemokine inhibitors (BSCIs) and their anti-inflammatory effects in vivo |
| Q51754950 | CAT-2003: A novel sterol regulatory element-binding protein inhibitor that reduces steatohepatitis, plasma lipids, and atherosclerosis in apolipoprotein E*3-Leiden mice. |
| Q43273465 | CREG inhibits migration of human vascular smooth muscle cells by mediating IGF-II endocytosis |
| Q39185553 | Cap inflammation leads to higher plaque cap strain and lower cap stress: An MRI-PET/CT-based FSI modeling approach |
| Q41166847 | Carotid plaque fissure: An underestimated source of intraplaque hemorrhage. |
| Q80171697 | Carotid plaque spaces relate to symptoms and ultrasound scattering |
| Q77644021 | Carotid rupture and intraplaque hemorrhage: immunophenotype and role of cells involved |
| Q89556307 | Cellular uptake of magnetic nanoparticles imaged and quantified by magnetic particle imaging |
| Q53507962 | Changing patterns of abnormal vascular wall F-18 fluorodeoxyglucose uptake on follow-up PET/CT studies. |
| Q38120657 | Changing views of the biomechanics of vulnerable plaque rupture: a review |
| Q39587428 | Characterization of fracture behavior of human atherosclerotic fibrous caps using a miniature single edge notched tensile test |
| Q40754222 | Characterization of the promoter of human extracellular matrix metalloproteinase inducer (EMMPRIN). |
| Q34101231 | Cholesterol and phospholipid metabolism in macrophages |
| Q42244011 | Cholesterol crystal embolization following plaque rupture: a systemic disease with unusual features |
| Q46775573 | Cholesterol crystals cause mechanical damage to biological membranes: a proposed mechanism of plaque rupture and erosion leading to arterial thrombosis. |
| Q38337452 | Clinical significance of macrophage phenotypes in cardiovascular disease. |
| Q35586584 | Clinical, biochemical, and immunohistochemical features of necrobiotic xanthogranulomatosis |
| Q50698610 | Comparison of 99mTc-annexin A5 with 18F-FDG for the detection of atherosclerosis in ApoE-/- mice. |
| Q37256939 | Concept of atherosclerosis velocity: is it a better measure of cardiovascular risk? |
| Q40459835 | Coronary Plaque Disruption |
| Q38315999 | Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications |
| Q41742301 | Current concepts in cardiovascular pathology: the role of LDL cholesterol in plaque rupture and stabilization |
| Q33993678 | Current, new and future treatments in dyslipidaemia and atherosclerosis |
| Q44205500 | Determination of the cholesterol-collagen ratio of arterial atherosclerotic plaques using near infrared spectroscopy as a possible measure of plaque stability |
| Q41887985 | Development of a quantitative mechanical test of atherosclerotic plaque stability |
| Q36914981 | Development of contrast agents targeted to macrophage scavenger receptors for MRI of vascular inflammation. |
| Q33936780 | Early decrease in carotid plaque lipid content as assessed by magnetic resonance imaging during treatment of rosuvastatin |
| Q81741255 | Effect of Shengmai Injection on cardiac function and inflammatory reaction in patients with acute coronary syndrome |
| Q34159732 | Effect of calcification on the mechanical stability of plaque based on a three-dimensional carotid bifurcation model |
| Q88598750 | Effect of distal thickening and stiffening of plaque cap on arterial wall mechanics |
| Q73254334 | Effect of short-term aspirin use on C-reactive protein |
| Q42115685 | Effects of intima stiffness and plaque morphology on peak cap stress |
| Q36421724 | Effects of mechanical properties and atherosclerotic artery size on biomechanical plaque disruption - mouse vs. human. |
| Q41379826 | Endothelial cell injury in cardiovascular surgery: atherosclerosis |
| Q41701279 | Endothelial dysfunction: a reversible clinical measure of atherogenic susceptibility and cardiovascular inefficiency |
| Q35013018 | Endothelial function. From vascular biology to clinical applications |
| Q41068586 | Endothelium, for example. |
| Q45714498 | Expression of Bcl-x, Bcl-2, Bax, and Bak in endarterectomy and atherectomy specimens |
| Q35751580 | Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall. A possible mechanism for aneurysm expansion |
| Q29036003 | Expression of tissue transglutaminase and elafin in human coronary artery |
| Q40464187 | Gene therapy for the vulnerable plaque |
| Q44474834 | High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes. |
| Q89533916 | High-resolution MRI assessed carotid atherosclerotic plaque characteristics comparing men and women with elevated ApoB levels |
| Q33671907 | Histopathology of plaque rupture |
| Q42861946 | Imaging of nanoparticles with dual-energy computed tomography |
| Q36892171 | Imaging techniques for the vulnerable coronary plaque. |
| Q41896880 | Impact of Fiber Structure on the Material Stability and Rupture Mechanisms of Coronary Atherosclerotic Plaques |
| Q31017247 | In Vivo Interrogation of the Molecular Display of Atherosclerotic Lesion Surfaces |
| Q36835335 | In vivo MRI-based simulation of fatigue process: a possible trigger for human carotid atherosclerotic plaque rupture |
| Q46268489 | In vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis |
| Q77111489 | Increased circulating monocyte activation in patients with unstable coronary syndromes |
| Q77753001 | Increased levels of monocyte-related cytokines in patients with unstable angina |
| Q37544889 | Inflammatory disease processes and interactions with nutrition |
| Q37557746 | Influence of conjugated linoleic acids on functional properties of vascular cells |
| Q78067780 | Inhibition of human arterial smooth muscle cell growth by human monocyte/macrophages: a co-culture study |
| Q35151262 | Intravascular elastography: from bench to bedside |
| Q34771396 | Intravascular ultrasound elastography: an overview |
| Q30460696 | Investigating the impact of spatial priors on the performance of model-based IVUS elastography |
| Q52527843 | Juxtalumenal location of plaque necrosis and neoformation in symptomatic carotid stenosis. |
| Q31038590 | Laser capture microdissection analysis of gene expression in macrophages from atherosclerotic lesions of apolipoprotein E-deficient mice |
| Q35745796 | Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death |
| Q54019589 | Localization of tissue transglutaminase in human carotid and coronary artery atherosclerosis: implications for plaque stability and progression. |
| Q40937611 | Macrophage Polarization in AIDS: Dynamic Interface between Anti-Viral and Anti-Inflammatory Macrophages during Acute and Chronic Infection |
| Q34762451 | Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases |
| Q41135115 | Macrophage-lysis mediated by autoantibodies to heat shock protein 65/60. |
| Q35753181 | Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro |
| Q37362401 | Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme |
| Q73154815 | Matrix metalloproteinase expression in nonrheumatic aortic stenosis |
| Q77738040 | Matrix metalloproteinase expression in the coronary circulation induced by coronary angioplasty |
| Q51571077 | Matrix metalloproteinase-12 gene regulation by a PPAR alpha agonist in human monocyte-derived macrophages. |
| Q35088065 | Mechanisms of plaque vulnerability and rupture |
| Q33954232 | Mitochondria in monocytes and macrophages-implications for translational and basic research |
| Q37138669 | New and emerging risk factors for CVD. |
| Q41531482 | New insights into the pathogenesis and prevention of acute coronary syndromes |
| Q39405721 | Nitroglycerin upregulates matrix metalloproteinase expression by human macrophages |
| Q30442501 | Non-rigid image registration based strain estimator for intravascular ultrasound elastography |
| Q40830644 | Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells |
| Q51071305 | Noninvasive two-dimensional strain imaging of arteries: validation in phantoms and preliminary experience in carotid arteries in vivo. |
| Q41762474 | Optical Coherence Tomography and Fibrous Cap Characterization |
| Q36468238 | Optical coherence tomography for imaging the vulnerable plaque |
| Q28195433 | Pathobiology, not angiography, should guide management in acute coronary syndrome/non-ST-segment elevation myocardial infarction: the non-interventionist's perspective |
| Q41047270 | Pathophysiology and inflammatory aspects of plaque rupture |
| Q41386371 | Pathophysiology of plaque rupture and the concept of plaque stabilization |
| Q39794861 | Peak cap stress calculations in coronary atherosclerotic plaques with an incomplete necrotic core geometry |
| Q33671913 | Plaque disruption and thrombosis. Potential role of inflammation and infection |
| Q79384414 | Plasma osteopontin levels are elevated in non-ST-segment elevation acute coronary syndromes |
| Q72049376 | Plasminogen Activator Expression in Human Atherosclerotic Lesions |
| Q37050963 | Positron emission tomography imaging of coronary atherosclerosis |
| Q71948888 | Prediction of acute coronary syndromes by percutaneous coronary angioscopy in patients with stable angina |
| Q37122524 | Primate models in women's health: inflammation and atherogenesis in female cynomolgus macaques (Macaca fascicularis) |
| Q72254127 | Probucol inhibits not only the progression of atherosclerotic disease, but causes a different composition of atherosclerotic lesions in WHHL-rabbits |
| Q78512141 | Prognostic value of C-reactive protein, fibrinogen, interleukin-6, and macrophage colony stimulating factor in severe unstable angina |
| Q30407251 | Quantitative sparse array vascular elastography: the impact of tissue attenuation and modulus contrast on performance |
| Q41612083 | Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo |
| Q35581960 | Raised concentrations of macrophage colony stimulating factor in severe unstable angina beyond the acute phase are strongly predictive of long term outcome |
| Q37361893 | Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability |
| Q38774904 | Readapting the adaptive immune response - therapeutic strategies for atherosclerosis |
| Q30912640 | Recent advances in ischaemic heart disease. |
| Q37199603 | Relationship between vitamin D deficiency and cardiovascular disease |
| Q51305795 | Robustness of reconstructing the Young's modulus distribution of vulnerable atherosclerotic plaques using a parametric plaque model. |
| Q34084212 | Role of plaque rupture in acute coronary syndromes |
| Q44404258 | Slowed Progression or Elimination of Atherosclerosis by Low-Frequency Electrical Impulses |
| Q30252988 | Smooth muscle cell-specific deletion of Col15a1 unexpectedly leads to impaired development of advanced atherosclerotic lesions |
| Q34779550 | Spotty calcification and plaque vulnerability in vivo: frequency-domain optical coherence tomography analysis |
| Q89967498 | Stress-Relaxation and Cyclic Behavior of Human Carotid Plaque Tissue |
| Q36090166 | Targeting the vulnerable plaque: the evolving role of nuclear imaging |
| Q73370951 | Tensile property of atheromatous plaque and an analysis of stress in atherosclerotic wall |
| Q37242352 | Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, reduces atherosclerosis in female low density lipoprotein receptor deficient mice |
| Q40436391 | The Role of Lipoproteins in Atherogenesis |
| Q92504508 | The Use of Nutraceuticals to Counteract Atherosclerosis: The Role of the Notch Pathway |
| Q87069700 | The pathogenesis of atherosclerosis: a critical evaluation of the evidence |
| Q33870602 | The role of plaque rupture and thrombosis in coronary artery disease |
| Q43690437 | The uptake and degradation of matrix-bound lipoproteins by macrophages require an intact actin Cytoskeleton, Rho family GTPases, and myosin ATPase activity. |
| Q37981725 | Therapeutic strategies to deplete macrophages in atherosclerotic plaques |
| Q35542584 | Towards understanding acute destabilization of vulnerable atherosclerotic plaques |
| Q51655897 | Ultrasound-induced encapsulated microbubble phenomena. |
| Q40925433 | Unstable angina: new insights into pathophysiologic characteristics, prognosis, and management strategies |
| Q35883085 | Using in vivo Cine and 3D multi-contrast MRI to determine human atherosclerotic carotid artery material properties and circumferential shrinkage rate and their impact on stress/strain predictions. |
| Q36422755 | Utilizing imaging tools in lipidology: examining the potential of MRI for monitoring cholesterol therapy |
| Q34171790 | Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis |
| Q34567958 | Vascular effects of TZDs: new implications |
| Q36019470 | Volumetric quantification of fibrous caps using intravascular optical coherence tomography |